⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Halden Pharma (HP Halden Pharma AS) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Halden Pharma (HP Halden Pharma AS)
↗Halden, Norway
Halden Pharma is one of Northern Europe's largest and most advanced sterile pharmaceutical manufacturing facilities, located in Halden, Norway. The company specializes in the production and distribution of IV bags, plastic ampoules (using Blow-Fill-Seal technology), vials, and other sterile and non-sterile pharmaceutical dosage forms.
Formerly operated by Fresenius Kabi, the site was acquired by the German family-owned Prange Group in 2024. The facility is a major CDMO (Contract Development and Manufacturing Organization) partner, holding multiple international certifications including EU-GMP, US FDA, and ANVISA, and serves leading global pharmaceutical companies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$15M-$40M
Founded:2024
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO)
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Prange Group
Acquired By:Prange Group (2024-01-01)
Key Partnerships:Prange Group (Owner), Adragos Group (Partner network)
COMPETITION
Position:Leader
Competitors:Agilera Pharma AS, Oncoinvent AS, LINK Medical Research
LEADERSHIP
Key Executives:
Ian Cooper - CEO
LINKS
Website:halden-pharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Halden Pharma (HP Halden Pharma AS). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.